KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Unitedhealth (UNH) Shares Outstanding (Diluted Average) (2016 - 2025)

Unitedhealth (UNH) has disclosed Shares Outstanding (Diluted Average) for 17 consecutive years, with $3.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Diluted Average) fell 62.5% to $3.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $3.0 million, a 62.5% decrease, with the full-year FY2025 number at $3.0 million, down 62.5% from a year prior.
  • Shares Outstanding (Diluted Average) was $3.0 million for Q4 2025 at Unitedhealth, down from $908.0 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $943.0 million in Q1 2023 to a low of $3.0 million in Q4 2025.
  • A 5-year average of $348.8 million and a median of $13.0 million in 2021 define the central range for Shares Outstanding (Diluted Average).
  • Peak YoY movement for Shares Outstanding (Diluted Average): soared 9190.0% in 2024, then crashed 99.57% in 2025.
  • Unitedhealth's Shares Outstanding (Diluted Average) stood at $13.0 million in 2021, then changed by 0.0% to $13.0 million in 2022, then surged by 7115.38% to $938.0 million in 2023, then plummeted by 99.15% to $8.0 million in 2024, then tumbled by 62.5% to $3.0 million in 2025.
  • Per Business Quant, the three most recent readings for UNH's Shares Outstanding (Diluted Average) are $3.0 million (Q4 2025), $908.0 million (Q3 2025), and $4.0 million (Q2 2025).